Pharmacotherapy of eating disorders.

Pharmacological treatment of binge eating disorder: update review and synthesis.

INTRODUCTION Binge eating disorder (BED), a formal eating disorder diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), is characterized by recurrent binge eating, marked distress about binge eating, and the absence of extreme weight compensatory behaviors. BED is more prevalent than other eating disorders, with broader distribution across age, sex and ethnic/racial g...

اختلالات روان‌پزشکی و بدکارکردی‌های جنسی

Sexual dysfunctions are highly prevalent among patients with psychiatric disorders. These dysfunctions may be caused by the psychopathology and pharmacotherapy of the psychiatric disorders. A lot of researches have studied the relationship between sexual dysfunctions and psychiatric disorders. The results of the researches show that psychiatric disorders have an important role in the developmen...

Binge eating disorder pharmacotherapy clinical trails--who is left out?

OBJECTIVE This report examined the characteristics of subjects interested in binge eating disorder (BED) pharmacotherapy trails who were ineligible for participation. METHODS Data on 2685 potential subjects interested in participating in five different placebo-controlled monotherapy trails of BED were analysed. RESULTS Of the 2685 potential subjects, 1230 (45.8%) were ineligible because the...

Pharmacological management of binge eating disorder: current and emerging treatment options

Growing evidence suggests that pharmacotherapy may be beneficial for some patients with binge eating disorder (BED), an eating disorder characterized by repetitive episodes of uncontrollable consumption of abnormally large amounts of food without inappropriate weight loss behaviors. In this paper, we provide a brief overview of BED and review the rationales and data supporting the effectiveness...

[Binge eating disorder: an emerging entity that responds to pharmacotherapy].

Comparing the Effectiveness of Metacognitive Therapy (MCT), Pharmacotherapy (SSRIs) and EEG Biofeedback in Generalized Anxiety Disorders

Background and Objective: Generalized Anxiety Disorder (GAD) is one of the most common psychological disorders characterized by excessive and uncontrollable worry and it has ahigh comorbidity with other anxiety disorders and depression. The aim of this study was to compare the efficacy of metacognitive therapy (MCT), pharmacotherapy and neurofeedback treatment in treating Iranian patients with ...